Published in Eur J Pharmacol on February 28, 2003
Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology (2010) 5.07
Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. Am J Psychiatry (2008) 2.51
Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A (2006) 2.25
Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci (2013) 2.23
Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology (Berl) (2007) 2.18
Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets (2006) 1.97
Anxiety dissociates dorsal and ventral medial prefrontal cortex functional connectivity with the amygdala at rest. Cereb Cortex (2010) 1.95
Restoring Acid-sensing ion channel-1a in the amygdala of knock-out mice rescues fear memory but not unconditioned fear responses. J Neurosci (2008) 1.90
A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology (2006) 1.90
Human bed nucleus of the stria terminalis indexes hypervigilant threat monitoring. Biol Psychiatry (2010) 1.80
Brain regions associated with the expression and contextual regulation of anxiety in primates. Biol Psychiatry (2005) 1.76
Assessing fear and anxiety in humans using the threat of predictable and unpredictable aversive events (the NPU-threat test). Nat Protoc (2012) 1.75
Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc Natl Acad Sci U S A (2008) 1.75
The bed nucleus of the stria terminalis mediates inter-individual variations in anxiety and fear. J Neurosci (2009) 1.69
Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis. Psychopharmacology (Berl) (2004) 1.69
Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biol Psychiatry (2009) 1.69
Neural activity associated with monitoring the oscillating threat value of a tarantula. Proc Natl Acad Sci U S A (2010) 1.62
Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology (2009) 1.62
Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest (2005) 1.57
5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biol Psychiatry (2009) 1.55
Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct (2008) 1.54
Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology (Berl) (2013) 1.53
Disruption of maternal parenting circuitry by addictive process: rewiring of reward and stress systems. Front Psychiatry (2011) 1.42
Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction. Biol Psychiatry (2010) 1.41
The anxiety disorder spectrum: fear imagery, physiological reactivity, and differential diagnosis. Anxiety Stress Coping (2009) 1.39
Cerebral blood flow in immediate and sustained anxiety. J Neurosci (2007) 1.38
Alcohol selectively reduces anxiety but not fear: startle response during unpredictable versus predictable threat. J Abnorm Psychol (2009) 1.37
Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions. Am J Physiol Regul Integr Comp Physiol (2010) 1.36
Contextual-specificity of short-delay extinction in humans: renewal of fear-potentiated startle in a virtual environment. Learn Mem (2007) 1.36
Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress. J Mol Neurosci (2010) 1.36
Epigenetic control of sexual differentiation of the bed nucleus of the stria terminalis. Endocrinology (2009) 1.35
Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affect. Psychoneuroendocrinology (2011) 1.32
Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens. Proc Natl Acad Sci U S A (2005) 1.29
Nonassociative learning processes determine expression and extinction of conditioned fear in mice. Learn Mem (2004) 1.27
Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J Neurosci (2008) 1.25
Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacol Biochem Behav (2007) 1.25
The role of the posterior medial bed nucleus of the stria terminalis in modulating hypothalamic-pituitary-adrenocortical axis responsiveness to acute and chronic stress. Psychoneuroendocrinology (2008) 1.24
Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl) (2006) 1.24
Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev (2012) 1.22
The genetics of sex differences in brain and behavior. Front Neuroendocrinol (2010) 1.21
Alcohol inhibits NR2B-containing NMDA receptors in the ventral bed nucleus of the stria terminalis. Neuropsychopharmacology (2007) 1.21
Signaling pathways mediating alcohol effects. Curr Top Behav Neurosci (2013) 1.20
Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction. Neurosci Biobehav Rev (2010) 1.19
Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun (2007) 1.17
The bed nucleus of the stria terminalis is critically involved in enhancing associative learning after stressful experience. Behav Neurosci (2005) 1.17
Effects of the beta-blocker propranolol on cued and contextual fear conditioning in humans. Psychopharmacology (Berl) (2004) 1.16
Orbitofrontal cortex lesions alter anxiety-related activity in the primate bed nucleus of stria terminalis. J Neurosci (2010) 1.16
Role of the bed nucleus of the stria terminalis in the control of ventral tegmental area dopamine neurons. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.15
Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl) (2010) 1.14
Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience (2009) 1.12
Orexin, stress, and anxiety/panic states. Prog Brain Res (2012) 1.11
The nonhuman primate amygdala is necessary for the acquisition but not the retention of fear-potentiated startle. Biol Psychiatry (2008) 1.10
Control of cell number in the sexually dimorphic brain and spinal cord. J Neuroendocrinol (2009) 1.10
Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res (2006) 1.10
Amygdala-dependent and amygdala-independent pathways for contextual fear conditioning. Neuroscience (2007) 1.08
Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology (2009) 1.08
Alcohol stress response dampening: selective reduction of anxiety in the face of uncertain threat. J Psychopharmacol (2011) 1.07
Functional MRI of the amygdala and bed nucleus of the stria terminalis during conditions of uncertainty in generalized anxiety disorder. J Psychiatr Res (2012) 1.07
Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models. Pharmacol Ther (2010) 1.06
Overlapping neurobiology of learned helplessness and conditioned defeat: implications for PTSD and mood disorders. Neuropharmacology (2011) 1.05
Chronic stress induces sex-specific alterations in methylation and expression of corticotropin-releasing factor gene in the rat. PLoS One (2011) 1.04
Sexual differentiation and development of forebrain reproductive circuits. Curr Opin Neurobiol (2010) 1.03
Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors. Br J Pharmacol (2005) 1.03
The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.03
The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. Psychopharmacology (Berl) (2010) 1.02
Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology (2007) 1.01
Increased acoustic startle responses in IBS patients during abdominal and nonabdominal threat. Psychosom Med (2008) 1.01
Identifying a network of brain regions involved in aversion-related processing: a cross-species translational investigation. Front Integr Neurosci (2011) 1.00
Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses. Neuropsychopharmacology (2008) 1.00
Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat. J Urol (2009) 1.00
Induction of Fos-immunoreactivity in the rat brain following disinhibition of the dorsomedial hypothalamus. Brain Res (2008) 0.99
Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology. Brain Behav Immun (2007) 0.99
The neuroendocrinology of social isolation. Annu Rev Psychol (2014) 0.98
Neurons in the amygdala with response-selectivity for anxiety in two ethologically based tests. PLoS One (2011) 0.98
Network organization unfolds over time during periods of anxious anticipation. J Neurosci (2014) 0.98
Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior. Biol Psychiatry (2007) 0.97
Timing of impulses from the central amygdala and bed nucleus of the stria terminalis to the brain stem. J Neurophysiol (2008) 0.97
Dispositional fear, negative affectivity, and neuroimaging response to visually suppressed emotional faces. Neuroimage (2011) 0.97
The bed nucleus of the stria terminalis modulates learning after stress in masculinized but not cycling females. J Neurosci (2008) 0.97
alpha2A-adrenergic receptors heterosynaptically regulate glutamatergic transmission in the bed nucleus of the stria terminalis. Neuroscience (2009) 0.96
Measuring anxious responses to predictable and unpredictable threat in children and adolescents. J Exp Child Psychol (2011) 0.96
Sex differences in molecular and cellular substrates of stress. Cell Mol Neurobiol (2012) 0.96
Inhibiting 5alpha-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats. Psychopharmacology (Berl) (2005) 0.96
A transcriptomic analysis of type I-III neurons in the bed nucleus of the stria terminalis. Mol Cell Neurosci (2011) 0.96
Forebrain networks and the control of feeding by environmental learned cues. Physiol Behav (2013) 0.96
Role of the bed nucleus of the stria terminalis in the acquisition and expression of conditioned defeat in Syrian hamsters. Behav Brain Res (2008) 0.96
Alcohol stress response dampening during imminent versus distal, uncertain threat. J Abnorm Psychol (2013) 0.95
Progestin receptor-mediated reduction of anxiety-like behavior in male rats. PLoS One (2007) 0.94
Prefrontal cortical contributions during discriminative fear conditioning, extinction, and spontaneous recovery in rats. Exp Brain Res (2010) 0.94
An ontology-based segmentation scheme for tracking postnatal changes in the developing rodent brain with MRI. Neuroimage (2012) 0.94
Effects of lidocaine-induced inactivation of the bed nucleus of the stria terminalis, the central or the basolateral nucleus of the amygdala on the opponent-process actions of self-administered cocaine in rats. Psychopharmacology (Berl) (2011) 0.94
Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol (2013) 0.94
Common brain activations for painful and non-painful aversive stimuli. BMC Neurosci (2012) 0.94
Sex differences in stress-induced social withdrawal: role of brain derived neurotrophic factor in the bed nucleus of the stria terminalis. Front Behav Neurosci (2014) 0.93
Disturbances in equilibrium function after major earthquake. Sci Rep (2012) 0.93
Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacology (2012) 0.93
The promise and predicament of cosmetic neurology. J Med Ethics (2006) 0.93
Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior. J Psychopharmacol (2008) 0.93
Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiol Behav (2012) 0.93
Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis. Neuroscience (2009) 0.92
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry (2004) 5.26
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ (2012) 4.64
Behavioral and neural analysis of extinction. Neuron (2002) 4.53
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci (2002) 4.52
A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry (2014) 4.25
Different mechanisms of fear extinction dependent on length of time since fear acquisition. Learn Mem (2006) 3.30
Applying learning principles to the treatment of post-trauma reactions. Ann N Y Acad Sci (2003) 3.05
Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med (2010) 2.83
Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci (2004) 2.73
Characterization of Bouveret's syndrome: a comprehensive review of 128 cases. Am J Gastroenterol (2006) 2.58
A significant decline in the American domination of research in gastroenterology with increasing globalization from 1980 to 2005: an analysis of American authorship among 8,251 articles. Am J Gastroenterol (2008) 2.53
Emotion, motivation, and the brain: reflex foundations in animal and human research. Prog Brain Res (2006) 2.52
Impaired fear inhibition is a biomarker of PTSD but not depression. Depress Anxiety (2010) 2.27
Regulation of synaptic plasticity genes during consolidation of fear conditioning. J Neurosci (2002) 2.10
Amygdala BDNF signaling is required for consolidation but not encoding of extinction. Nat Neurosci (2006) 2.10
Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct Funct (2008) 1.97
Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology (2005) 1.89
The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav (2002) 1.87
Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. Learn Mem (2006) 1.78
Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity. Psychiatry Res (2009) 1.76
Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J Neurosci (2005) 1.72
Conditioned pharmacotherapeutic effects: a preliminary study. Psychosom Med (2009) 1.68
Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biol Psychiatry (2005) 1.65
Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency. Pediatr Transplant (2007) 1.54
Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learn Mem (2004) 1.53
Impaired safety signal learning may be a biomarker of PTSD. Neuropharmacology (2011) 1.52
Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology (2010) 1.51
Fear potentiation and fear inhibition in a human fear-potentiated startle paradigm. Biol Psychiatry (2005) 1.49
Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts. Eur Urol (2009) 1.49
Timing of extinction relative to acquisition: a parametric analysis of fear extinction in humans. Behav Neurosci (2008) 1.45
Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.44
"Hidden" social networks in behavior change interventions. Am J Public Health (2015) 1.41
Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.40
Early intervention may prevent the development of posttraumatic stress disorder: a randomized pilot civilian study with modified prolonged exposure. Biol Psychiatry (2012) 1.37
Learning-dependent structural plasticity in the adult olfactory pathway. J Neurosci (2008) 1.34
Brain-derived neurotrophic factor in amygdala-dependent learning. Neuroscientist (2005) 1.31
Contingency awareness and fear inhibition in a human fear-potentiated startle paradigm. Behav Neurosci (2006) 1.30
The effect of gonadal hormones and gender on anxiety and emotional learning. Horm Behav (2006) 1.29
The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol (2003) 1.29
Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression. Learn Mem (2005) 1.28
AX+, BX- discrimination learning in the fear-potentiated startle paradigm: possible relevance to inhibitory fear learning in extinction. Learn Mem (2004) 1.24
Temporary disruption of fear-potentiated startle following PKMζ inhibition in the amygdala. Nat Neurosci (2011) 1.23
Light-enhanced startle: further pharmacological and behavioral characterization. Psychopharmacology (Berl) (2001) 1.21
Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral responses to social defeat. Behav Neurosci (2004) 1.20
Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans. Am J Psychiatry (2002) 1.18
Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev (2009) 1.18
Olfactory-mediated fear-potentiated startle. Behav Neurosci (2002) 1.18
Daily living with distress and enrichment: the moral experience of families with ventilator-assisted children at home. Pediatrics (2006) 1.17
Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology (Berl) (2002) 1.16
Effects of the beta-blocker propranolol on cued and contextual fear conditioning in humans. Psychopharmacology (Berl) (2004) 1.16
Acoustic startle, prepulse inhibition, and fear-potentiated startle measured in rhesus monkeys. Biol Psychiatry (2002) 1.15
Tools for translational neuroscience: PTSD is associated with heightened fear responses using acoustic startle but not skin conductance measures. Depress Anxiety (2011) 1.14
The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci (2008) 1.14
Acute thrombosis of the inferior vena cava. Am J Emerg Med (2006) 1.13
Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD. Psychoneuroendocrinology (2009) 1.13
Strengthening the emergency healthcare system for mothers and children in The Gambia. Reprod Health (2010) 1.13
Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test. Learn Mem (2008) 1.10
The nonhuman primate amygdala is necessary for the acquisition but not the retention of fear-potentiated startle. Biol Psychiatry (2008) 1.10
Memory of social defeat is facilitated by cAMP response element-binding protein overexpression in the amygdala. Behav Neurosci (2005) 1.10
Estrogen disrupts the inhibition of fear in female rats, possibly through the antagonistic effects of estrogen receptor alpha (ERalpha) and ERbeta. J Neurosci (2007) 1.09
Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. J Neurosci (2011) 1.08
Role of the primate amygdala in fear-potentiated startle: effects of chronic lesions in the rhesus monkey. J Neurosci (2007) 1.07
Olfactory-mediated fear conditioning in mice: simultaneous measurements of fear-potentiated startle and freezing. Behav Neurosci (2005) 1.06
Physical activity loyalty cards for behavior change: a quasi-experimental study. Am J Prev Med (2013) 1.06
Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone. Biol Psychiatry (2006) 1.05
Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. Cancer Epidemiol Biomarkers Prev (2009) 1.02
Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J Neurosci (2004) 1.02
Systems-level reconsolidation: reengagement of the hippocampus with memory reactivation. Neuron (2002) 1.01
Men with prostate cancer make positive dietary changes following diagnosis and treatment. Cancer Causes Control (2013) 1.01
Differential regional expression of brain-derived neurotrophic factor following olfactory fear learning. Learn Mem (2007) 1.01
Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses. Neuropsychopharmacology (2008) 1.00
Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning. Neuropsychopharmacology (2008) 1.00
Hoechst-IR: an imaging agent that detects necrotic tissue in vivo by binding extracellular DNA. Org Lett (2010) 0.98
Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway. Cancer (2014) 0.98
Fear-potentiated startle in rats is mediated by neurons in the deep layers of the superior colliculus/deep mesencephalic nucleus of the rostral midbrain through the glutamate non-NMDA receptors. J Neurosci (2004) 0.97
Effects of cocaine self-administration history under limited and extended access conditions on in vivo striatal dopamine neurochemistry and acoustic startle in rhesus monkeys. Psychopharmacology (Berl) (2009) 0.96
The nucleus accumbens is not critically involved in mediating the effects of a safety signal on behavior. Neuropsychopharmacology (2005) 0.96
Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone. Psychopharmacology (Berl) (2008) 0.93
Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: vascular complications and incidence of bleeding. Acute Card Care (2012) 0.93
Use of complementary and alternative medicine in children with asthma. Can Respir J (2010) 0.93
Inhibition of fear is differentially associated with cycling estrogen levels in women. J Psychiatry Neurosci (2013) 0.93
Phasic and sustained fear are pharmacologically dissociable in rats. Neuropsychopharmacology (2011) 0.92
Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review. Adverse Drug React Toxicol Rev (2002) 0.91
Sex differences in hormonal modulation of anxiety measured with light-enhanced startle: possible role for arginine vasopressin in the male. J Neurosci (2005) 0.90
Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk. PLoS One (2010) 0.90
A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study). Contemp Clin Trials (2006) 0.89
A metaplasticity-like mechanism supports the selection of fear memories: role of protein kinase a in the amygdala. J Neurosci (2012) 0.88
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary. Clin Interv Aging (2010) 0.88
Gleason drift in the NIHR ProtecT study. Histopathology (2015) 0.87
AX+/BX- discrimination learning in the fear-potentiated startle paradigm in monkeys. Learn Mem (2008) 0.87
Effects of neonatal amygdala lesions on fear learning, conditioned inhibition, and extinction in adult macaques. Behav Neurosci (2012) 0.87
A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom. Cancer Causes Control (2012) 0.87
The role of dopaminergic agents in improving quality of life in major depressive disorder. Curr Psychiatry Rep (2009) 0.86
Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle. Neuropsychopharmacology (2008) 0.86
Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy. Eur Urol (2012) 0.86
Surprising dependence on postsegregational killing of host cells for maintenance of the large virulence plasmid of Shigella flexneri. J Bacteriol (2005) 0.85
Group II metabotropic glutamate receptors within the amygdala regulate fear as assessed with potentiated startle in rats. Behav Neurosci (2002) 0.85
Acute stress disorder versus chronic posttraumatic stress disorder: inhibition of fear as a function of time since trauma. Depress Anxiety (2012) 0.85
Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev (2011) 0.84